Navigation Links
Supercomputers help ORNL researchers identify key molecular switch that controls cell behavior
Date:12/17/2013

OAK RIDGE, Tenn., Dec. 17, 2013 If scientists can control cellular functions such as movement and development, they can cripple cells and pathogens that are causing disease in the body.

Supported by National Institutes of Health grants, researchers at Oak Ridge National Laboratory (ORNL), the University of Tennessee (UT), and the UTORNL Joint Institute for Computational Sciences (JICS) discovered a molecular "switch" in a receptor that controls cell behavior using detailed molecular dynamics simulations on a computer called Anton built by D. E. Shaw Research in New York City. To study an even larger signaling complex surrounding the switch, the team is expanding these simulations on the 27-petaflop, CPUGPU machine Titanthe nation's most powerful supercomputer, managed by the Oak Ridge Leadership Computing Facility at ORNL.

Researchers identified the molecular switch on Anton (which was designed to perform speedy molecular dynamics simulations) by simulating 140,000 atoms that make up the signaling part of the Tsr chemoreceptor that controls motility in E. coli. Like other receptors, Tsr spans the cell membrane, communicating to proteins inside the cell in order to respond to threats or opportunities in the environment.

The results, published in Nature Communications, stand apart from previous research because of the computational power applied to the problem.

"This work exemplifies the growing importance of numerical experiments in biology," said Jerome Baudry, assistant professor in the UT Biochemistry and Cellular and Molecular Biology Department and the UTORNL Center for Molecular Biophysics.

The team led by Baudry and Igor Zhulin, distinguished research and development staff member in the ORNL Computer Science and Mathematics Division, joint professor in the UT Department of Microbiology, and JICS joint faculty member determined that a single pair of phenylalanine amino acids called Phe396 located at the chemoreceptor tip was acting as a receptor switch.

"For decades proteins have been viewed as static molecules, and almost everything we know about them comes from static images, such as those produced with X-ray crystallography," Zhulin said. "But signaling is a dynamic process, which is difficult to fully understand using only snapshots."

The Phe396 pair is restless, always flipping 180 degrees back and forth relative to the receptor, but researchers identified a clear pattern.

"It is like a crazy light switch," Zhulin said. "When you switch it on to light up your room, it occasionally flips down giving you moments of darkness, and when you switch it off to go to sleep, it occasionally goes up flashing."

When the receptor is in signal-on mode, the switch spends more time in the "on" position. When the receptor is in signal-off mode, the switch spends more time in the "off" position.

"To our knowledge, this is the first time this switch has been described," said Davi Ortega, lead author and postdoctoral fellow in Zhulin's lab.

The team, including collaborators at the University of Utah led by John Parkinson, compared thousands of chemoreceptor sequences from all microbial genomes in the Microbial Signal Transduction database available as of August 2012. Remarkably, the Phe396 amino acid was present in all of them, indicating it is likely the switch has existed throughout more than 2 billion years of microbial evolution.

Phenylalanine pairs capable of forming a molecular switch are also present in many other signaling proteins, including receptors in human cells, making it an attractive target for drug design and biotechnology applications.

However, using Anton, researchers were able to simulate only a small part of the chemoreceptor containing the Phe396 pair known as a dimer, meaning two identical molecules. But these two molecules do not work alone.

Dimers are grouped in threes to form larger units of the signaling complex, called trimers of dimers. Researchers expect simulating a trimer next will reveal more about how the Phe396-mediated signal is amplified across neighboring proteins.

But a trimer simulation requires modeling almost 400,000 atoms with increasingly complex physics calculations as the system gets larger. To do so, the group needs a lot of computational capacity.

"Anton is an exceptional machine, but its hardware limitations won't permit the simulation of such a large system," Ortega said. "We need Titan."

Using Titan they ran a preliminary simulation to determine that they would need millions of processing hours on this petaflop machine capable of quadrillions of calculations per second. Titan's GPUs are highly parallel, hurtling through repetitive calculations such as those modeling the large system of atoms under a vast array of configurations in the trimer simulation.

"With Titan we will begin to see how the signal propagates across chemoreceptors," Zhulin said. "We think this will start to explain how signals are amplified by these remarkable molecular machines."


'/>"/>

Contact: Katie Jones
joneske1@ornl.gov
865-241-6088
DOE/Oak Ridge National Laboratory
Source:Eurekalert  

Related medicine news :

1. Iowa VP for Research addresses next-generation supercomputers at congressional hearing
2. Feinstein Institute researchers show a genetic overlap in schizophrenia and cognitive ability
3. Minorities health would benefit most from beverage sugar tax, UCSF researchers report
4. Wake Forest Baptist researchers study alcohol addiction using optogenetics
5. Researchers discover common cell wall component in Chlamydia bacteria
6. Researchers at Mount Sinai Say a New Strain of Bird Flu Packs a Punch Even After It Becomes Resistant to Drugs
7. OHSU researchers develop new drug approach that could lead to cures for wide range of diseases
8. Keep on exercising, researchers advise older breast cancer survivors
9. CU researchers may have discovered a plan to disable Menieres disease
10. Norwegian brain researchers share Horwitz prize
11. RI researchers validate tool for pain assessment in patients following cardiac surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Supercomputers help ORNL researchers identify key molecular switch that controls cell behavior
(Date:5/24/2017)... ... ... are thinking of a visit to San Francisco , fall is a great time ... visit. , Business Architecture Associates is pleased to offer 5 days of training courses, available ... package for individuals, and as 4-½ day corporate package for up to 3 employees with ...
(Date:5/24/2017)... ... May 24, 2017 , ... The CFOs included ... and health systems in the nation and help their organizations navigate the challenges ... and been instrumental in developing successful hospital and health system strategy. , Becker's ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... sleep diagnostics sensors, announced today it had completed the first phase of building ... of domestic and rest of world (ROW) authorized dealers specializing in polysomnography accessories. ...
(Date:5/23/2017)... ... ... Allegheny Health Network and the Alexis Joy D’Achille Foundation ... at West Penn Hospital , a unique facility that will offer the most ... Construction of the Center is underway with a scheduled opening in the fall of ...
(Date:5/23/2017)... N.Y. (PRWEB) , ... May 23, 2017 , ... New ... Public Health Crisis Worthy of a Policy Response”, -The Rory Staunton Foundation Calls on ... Staunton Foundation for the Prevention of Sepsis ( http://www.rorystauntonfoundation.org ) today reported on a ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
(Date:5/6/2017)... is Stroke Awareness Month and Omron Healthcare is reminding ... prevent a stroke: monitor and manage your blood pressure. ... undetected and uncontrolled hypertension is a leading risk factor ... personal heart health technology, recently evolved its mission to ... and is advancing a national public education effort to ...
(Date:5/4/2017)... and SAN DIEGO , May 4, ... (ACOG) 2017 Annual Clinical and Scientific Meeting— OBP Medical ... medical devices, today announced the launch of a new ... OfficeSPEC and ER-SPEC vaginal specula. Already ... extra-small and extra-large sizes makes OBP Medical,s line of ...
Breaking Medicine Technology: